Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 8 , Pages 979-983 , August 2007

Staphylococcus aureus Colonization in Community-Dwelling People With Spinal Cord Dysfunction

  • Mary-Claire Roghmann, MD, MS

      Affiliations

    • VA Maryland Health Care System, Baltimore, MD
    • Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD
    • Corresponding Author InformationCorrespondence to Mary-Claire Roghmann, MD, MS, 100 N Greene St (Lower level), Baltimore, MD 21201
    • ,
  • Peter H. Gorman, MD

      Affiliations

    • Department of Neurology, University of Maryland School of Medicine, Baltimore, MD
    • ,
  • Mitchell T. Wallin, MD

      Affiliations

    • Department of Neurology Georgetown University School of Medicine and VA Medical Center, Washington, DC.
    • ,
  • Kristen Kreisel, MS

      Affiliations

    • Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD
    • ,
  • Simone Shurland, MS

      Affiliations

    • Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD
    • ,
  • Judith A. Johnson, PhD

      Affiliations

    • VA Maryland Health Care System, Baltimore, MD
    • Department of Pathology, University of Maryland School of Medicine, Baltimore, MD

References 

  1. Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis. 2003;187:1452–1459
  2. Montgomerie JZ. Infections in patients with spinal cord injuries. Clin Infect Dis. 1997;25:1285–1290
  3. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–762
  4. Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004;364:703–705
  5. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis (Efficacy of antibiotic prophylaxis). N Engl J Med. 1986;315:91–96
  6. Perl TM, Cullen JJ, Wenzel RP, et al. Mupirocin and the Risk of Staphylococcus Aureus Study Team (Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections). N Engl J Med. 2002;346:1871–1877
  7. Peacock SJ, de Silva I, Lowy FD. What determines nasal carriage of Staphylococcus aureus?. Trends Microbiol. 2001;9:605–610
  8. Ridley M. Perineal carriage of Staph aureus. Br Med J. 1959;1(5117):270–273
  9. Squier C, Rihs JD, Risa KJ, et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol. 2002;23:495–501
  10. Olona-Cabases M, Tico-Falguera N, Ramirez-Garceran L, Del Valle-Ortiz O, Castello-Verdu T, Garcia-Fernandez L. Methicillin-resistant Staphylococcus aureus: a four-year experience in a spinal cord injury unit in Spain. Spinal Cord. 1996;34:315–319
  11. Maeder K, Ginunas VJ, Montgomerie JZ, Canawati HN. Methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with spinal cord injury. Paraplegia. 1993;31:639–644
  12. Aeilts GD, Sapico FL, Canawati HN, Malik GM, Montgomerie JZ. Methicillin-resistant-Staphylococcus aureus colonization and infection in a rehabilitation facility. J Clin Microbiol. 1982;16:218–223
  13. Roghmann MC, Wallin MT, Gorman PH, Johnson JA. Prevalence and natural history of colonization with fluoroquinolone-resistant gram-negative bacilli in community-dwelling people with spinal cord dysfunction. Arch Phys Med Rehabil. 2006;87:1305–1309
  14. Multiple Sclerosis Council for Clinical Practice Guidelines. In: Urinary dysfunction and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington (DC): Paralyzed Veterans of America; 1999;p. 1–16
  15. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655
  16. Kurtzke JF. Clinical definition for multiple sclerosis treatment trials. Ann Neurol. 1994;36(Suppl):S73–S79
  17. American Spinal Injury Association. International standards for neurological classification of SCI. Atlanta: ASIA; 2002;
  18. Jones EM, Bowker KE, Cooke R, Marshall RJ, Reeves DS, MacGowan AP. Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J Hosp Infect. 1997;35:59–62
  19. VandenBergh MF, Yzerman EP, van Belkum A, Boelens HA, Sijmons M, Verbrugh HA. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol. 1999;37:3133–3140
  20. Hugenholtz P, Goebel BM, Pace NR. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol. 1998;180:4765–4774
  21. Harmsen D, Claus H, Witte W, Rothganger J, Turnwald D, Vogel U. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol. 2003;41:5442–5448
  22. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113–5120
  23. Blumberg HM, Rimland D, Carroll DJ, Terry P, Wachsmuth IK. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis. 1991;163:1279–1285
  24. Bisognano C, Vaudaux P, Rohner P, Lew DP, Hooper DC. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother. 2000;44:1428–1437
  25. Dziekan G, Hahn A, Thune K, et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect. 2000;46:263–270
  26. Salgado CD, Farr BM. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures?. Infect Control Hosp Epidemiol. 2006;27:116–121
  27. Siegel JD, Rhinehart E, Jackson M, Chiarello L Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings. 2006;Available at: URL: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed April 17, 2007.
  28. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505–520
  29. Eriksen NH, Espersen F, Rosdahl VT, Jensen K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect. 1995;115:51–60

 Supported by a VA Merit Review Grant, University of Maryland School of Medicine General Clinical Research Center (grant no. M01-RR-16500), and a Merck Medical School Grant.

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

 Reprints are not available from the author.

PII: S0003-9993(07)00348-6

doi: 10.1016/j.apmr.2007.05.005

Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 8 , Pages 979-983 , August 2007

Article Tools